Web seminar recordings

QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in hematological tumors

December 08, 2016
Hematological malignancies originating from hematopoietic and lymphoid tissue are complex heterogeneous diseases characterized by distinct clinicopathological features and molecular alterations. The heterogeneity of leukemia and lymphoma has presented massive challenges for identifying the appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond standard of care and chemotherapy. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of clinically actionable variants from NGS data in clinical genomics laboratories.

Interested in learning more?

Click here

Related videos

Web seminar recordings

Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characterization of the...

1,267 views December 20, 2016

High-throughput sequencing, combined with high-resolution metagenomic...

Web seminar recordings

Part 1: Use of QCI Interpret to elucidate precision in breast cancer targeted therapy

1,482 views October 24, 2016

Breast cancer is a complex heterogeneous disease, with each subtype...

Web seminar recordings

QIAGEN Clinical Insight - Overview and demonstration

1,927 views August 07, 2015

Learn about the key capabilities of QCI, and get a QCI somatic cancer...